News | April 12, 2026
Eli Lilly launches once-daily weight-loss pill Foundayo
The once-daily oral medication is approved for adults with obesity or overweight who have weight-related medical conditions
The once-daily oral medication is approved for adults with obesity or overweight who have weight-related medical conditions
Routine regulatory filing confirms completion of demat and share transfer compliances for March quarter
The improved score reflects a stronger ESG profile for the Ahmedabad-based drugmaker
The initiative is a significant step toward combating antimicrobial resistance (AMR) and reducing environmental contamination from antibiotic waste
The FDA clearance of Zeto New Wave marks the company’s third cleared device, alongside Zeto WR19 and Zeto ONE
The device aims to bring precision neuroscience into clinical trials, accelerating drug development
The approval clears the way for a US study at leading clinical centers to evaluate the safety and effectiveness of VDYNE’s system in patients
The dual expansion simplifies transcriptomics workflows by combining faster regional turnaround with easier sample logistics
The biggest highlight was Project Vimana, a drone-deployed battlefield trauma surgery system engineered to bring life-saving surgical intervention
Former Global Head of IT & Digital Transformation at Biocon Biologics steps into enterprise-wide technology leadership role
Subscribe To Our Newsletter & Stay Updated
